Burden of Clostridium difficile on the Healthcare System.
Clin Infect Dis. 2012 Aug;55 Suppl 2:S88-92
Authors: Dubberke ER, Olsen MA
There are few high-quality studies of the costs of Clostridium difficile infection (CDI), and the majority of studies focus on the costs of CDI in acute-care facilities. Analysis of the best available data, from 2008, indicates that CDI may have resulted in $4.8 billion in excess costs in US acute-care facilities. Other areas of CDI-attributable excess costs that need to be investigated are costs of increased discharges to long-term care facilities, of CDI with onset in long-term care facilities, of recurrent CDI, and of additional adverse events caused by CDI.
PMID: 22752870 [PubMed - in process]